中国麻风皮肤病杂志 ›› 2023, Vol. 39 ›› Issue (10): 758-763.doi: 10.12144/zgmfskin202310758

• 综述 • 上一篇    下一篇

光敏性药疹的诊疗研究进展

周鑫,晏洪波,陈小强   

  1. 中部战区总医院,湖北武汉,430070
  • 出版日期:2023-10-15 发布日期:2023-10-12

Update of diagnosis and treatment of drug-induced photosensitivity

ZHOU Xin, YAN Hongbo, CHEN Xiaoqiang   

  1. Central Theater General Hospital, Wuhan 430070, China
  • Online:2023-10-15 Published:2023-10-12

摘要: 光敏性药疹是指光敏性药物(局部或者全身给药)和紫外线(UVA 320~400 nm、UVB 290~320 nm)、可见光(400~700 nm)的联合相互作用下发生的皮肤疾病。一般情况下,可分为光过敏反应和光毒性反应。本文主要对光敏性药疹的分类、发病机制、诊断、鉴别诊断、光敏药物、治疗进行综述,以期为光敏性药疹的诊断和治疗提供新思路。

关键词: 光敏性药疹, 发病机制, 诊断, 光敏药物

Abstract: Drug-induced photosensitivity refers to photosensitive drugs (local or systemic administration) and ultraviolet rays (UVA320-400 nm, UVB290-320 nm) and visible light (400-700 nm). In general, it can be divided into photo-allergic reaction and photo-toxic reaction. This paper mainly reviews the classification, pathogenesis, diagnosis, differential diagnosis, photosensitive drugs and treatment of drug-induced photosensitivity, in order to provide new ideas to diagnose and treat drug-induced photosensitivity.

Key words: drug-induced photosensitivity, pathogenesis, diagnosis, photosensitive drugs